Chronic News and Research

RSS

New Scientific Statement outlines future research directions for type 1 diabetes

A new Scientific Statement released today by the Endocrine Society highlights potential research directions related to the pathogenesis of type 1 diabetes (T1D) that should help with the development of new and improved treatment options.

9 Jul 2025

Redefining Alzheimer’s development by mapping disease sequences

UCLA's study identifies distinct Alzheimer's disease trajectories, emphasizing the role of shared risk factors in early detection and targeted interventions.

9 Jul 2025

Many Americans misunderstand the health impact of processed foods

Thirty-nine percent of respondents to an online poll incorrectly said all processed foods are unhealthy, according to new research by the Physicians Committee for Responsible Medicine published today, July 8, 2025, in JAMA Network Open.

9 Jul 2025

Children’s health in the United States is declining across multiple measures

A new study led by researchers at Children's Hospital of Philadelphia (CHOP) has found that children's health in the United States is declining across several key measurements ranging from increased chronic illnesses, higher rates of physical and mental health conditions and related symptoms, and increased mortality rates compared with other countries.

9 Jul 2025

World’s premier cancer institute faces crippling cuts and chaos

The Trump administration's broadsides against scientific research have caused unprecedented upheaval at the National Cancer Institute, the storied federal government research hub that has spearheaded advances against the disease for decades.

9 Jul 2025

Why vitamin B6 could raise the risk of hypoglycemia for people with diabetes

A large-scale Mendelian randomization study found no genetic evidence that vitamins A, C, or D reduce the risk of major diabetic complications. However, higher genetically predicted vitamin B6 levels were strongly associated with increased risk of diabetic hypoglycemia, warranting caution with supplementation.

8 Jul 2025

Vaping linked to higher COPD risk, meta-analysis finds

A comprehensive meta-analysis of over 4.3 million adults shows e-cigarette use is associated with significantly higher odds of developing COPD. The risk persists even after adjusting for smoking history, with former users at even greater risk than current users.

8 Jul 2025

Gamma knife radiosurgery shows high tumor control in brain metastases from ovarian cancer

Brain metastases from ovarian cancer (BMFOC) are rare but associated with poor prognosis. This study aimed to evaluate the efficacy and safety of Gamma Knife stereotactic radiosurgery (GKSRS) in managing patients with BMFOC.

8 Jul 2025

Shaping the future of psychiatry with precision medicine

In a comprehensive Genomic Press Interview published today in Genomic Psychiatry, Dr. Mirko Manchia opens up about his transformative journey from a small Sardinian city to becoming a leading voice in psychiatric pharmacogenomics, revealing how personal family experiences with mental illness sparked a lifelong quest to understand why psychiatric medications work brilliantly for some patients while failing others.

8 Jul 2025

Uncovering the hidden dangers of artificial light exposure

In a comprehensive Genomic Press Innovators & Ideas interview published today, distinguished neuroscientist Dr. Randy J. Nelson shares insights from his pioneering research on how disrupted circadian rhythms affect brain function and overall health.

8 Jul 2025

New study reveals housing crisis as major health challenge

A new study sheds light on the hidden health crisis linked to poor housing conditions in Israel. Drawing on global research and local data, the authors call for an urgent, interdisciplinary effort to reform housing policy as a matter of public health.

8 Jul 2025

SolasCure publishes Dose Escalation Study on painless application of Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the publication of a peer-reviewed study in the International Wound Journal.

8 Jul 2025

Adding anxiety to Pennsylvania's medical cannabis program changes patient demographics

Within months of Pennsylvania's medical cannabis program adding anxiety as a qualifying condition, that diagnosis quickly rose to become the most common for cannabis certifications, according to a study by researchers at the University of Pittsburgh and Johns Hopkins University. The study was published today in Annals of Internal Medicine.

8 Jul 2025

Tirzepatide tops the charts for blood sugar and weight loss in type 2 diabetes

A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with type 2 diabetes. Tirzepatide demonstrated the greatest efficacy for glucose control and weight loss, while liraglutide offered the lowest hypoglycemia risk.

7 Jul 2025